The drug development sector in the United States is experiencing a substantial surge in demand for Tirzepatide APIs. This powerful medication, used to treat glucose intolerance, has captured extensive attention from both individuals and medical practitioners. As a result, numerous manufacturers have emerged as producers of Tirzepatide APIs in the U